Skip to content
★ Sign in to follow
ApicHope Pharmaceutical Group Co., Ltd. logo

ApicHope Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China

一品红

CN·Mcap CN¥13.8BHealth Care

No insider purchase over the last 90 days. The latest, by 张克坚, was filed 31 Dec 2025.

ApicHope Pharmaceutical Group Co., Ltd.: what insiders have been doing

ApicHope Pharmaceutical Group Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Over the twelve months to 5 November 2026, 2 filings were filed, from 1 insider.

Only purchases show up on the open market, 2 purchases in all worth €59k, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. At €42k, the purchase published on 21 November 2025 by 张克坚 is the largest of the period. Those buying include 1 board member.

For context, the typical company on the same exchange (median of 521 companies) published 2 filings over the same period, against 2 filings here. The full history, which starts in 2021, counts 3 purchases against 3 sales.

The most recent open-market purchase was published on 31 December 2025, 312 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€197,056
3 ops. · all time
Sell Volume
€97,113
3 ops. · all time

Who traded when

BuySale
张克坚2 buys

Since the insiders bought

  • Filed 31 Dec 2025 · 312 days ago · €17k
    -21.3%
    Entry CN¥35.84 · Close 03 Nov 2026 CN¥28.22
  • Filed 07 Nov 2022 · 1462 days ago · €138k
    +48.8%
    Entry CN¥20.86 · Close at T+365 CN¥31.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 18,068 of 26,914 companies
40.3
score / 100
Value
30
Quality
50
FCF yld-0.6%
Earn yld-2.4%
EV/EBITDA·
ROE11%
Gross mgn56%
Net mgn-36%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥30.53
Analyst consensus
·
Income statement
RevenueCN¥932.3M
Gross profitCN¥526.5M56% margin
EBITDA-CN¥96.7M-10% margin
Net income-CN¥337.8M26.2% margin
Valuation
PER (trailing)63.6x
P/Book7.4x
Beta0.75
Balance sheet & cash
Market capCN¥13.8B
Total debtCN¥2.1B
Free Cash Flow-CN¥81.2M
Debt / Equity109%
Profitability & ownership
ROE11.4%
ROA-4.3%
% insiders68.2%
% institutions1.7%
Last declaration on 31 December 2025
Declarations6 total
  • ▲
    独立董事Executives
    140,700 CNY10SZSE
    4,200 shares29.0% of flowA股XSHESZSE:273000000087558080
    Canonical exit: 31 Mar 2026 (T+90)
  • ▲
    独立董事Executives
    343,980 CNY14SZSE
    7,000 shares71.0% of flowA股XSHESZSE:173000009823668060
    Canonical exit: 19 Feb 2026 (T+90)
  • ▲
    董秘Executives
    987,734 CNY15SZSE
    32,300 shares100.0% of flowA股XSHESZSE:173000006015955970
    Canonical exit: 5 Feb 2023 (T+90)
  • ▼
    监事Executives
    29,340 CNY15SZSE
    900 shares100.0% of flowA股XSHESZSE:173000005059258780
  • ▼
    董事Executives
    348,960 CNY12SZSE
    12,000 shares48.6% of flowA股XSHESZSE:173000004746169120
  • ▼
    董事Executives
    370,328 CNY12SZSE
    13,600 shares51.4% of flowA股XSHESZSE:173000004746169150

6 of 6 declarations

About ApicHope Pharmaceutical Group Co., Ltd.

一品红 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of medicines and pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations